{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:27:38Z","timestamp":1790537258654,"version":"4.1.0"},"reference-count":67,"publisher":"American Society for Clinical Investigation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,6]]},"abstract":"<jats:p>Myasthenia gravis (MG) with anti\u2013acetylcholine receptor (AChR) Abs is an autoimmune disease characterized by severe defects in immune regulation and thymic inflammation. Because mesenchymal stem cells (MSCs) display immunomodulatory features, we investigated whether and how in vitro\u2013preconditioned human MSCs (cMSCs) could treat MG disease. We developed a new humanized preclinical model by subcutaneously grafting thymic MG fragments into immunodeficient NSG mice (NSG-MG model). Ninety percent of the animals displayed human anti-AChR Abs in the serum, and 50% of the animals displayed MG-like symptoms that correlated with the loss of AChR at the muscle endplates. Interestingly, each mouse experiment recapitulated the MG features of each patient. We next demonstrated that cMSCs markedly improved MG, reducing the level of anti-AChR Abs in the serum and restoring AChR expression at the muscle endplate. Resting MSCs had a smaller effect. Finally, we showed that the underlying mechanisms involved (a) the inhibition of cell proliferation, (b) the inhibition of B cell\u2013related and costimulatory molecules, and (c) the activation of the complement regulator DAF\/CD55. In conclusion, this study shows that a preconditioning step promotes the therapeutic effects of MSCs via combined mechanisms, making cMSCs a promising strategy for treating MG and potentially other autoimmune diseases.<\/jats:p>","DOI":"10.1172\/jci.insight.89665","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T22:24:53Z","timestamp":1491517493000},"source":"Crossref","is-referenced-by-count":39,"title":["Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model"],"prefix":"10.1172","volume":"2","author":[{"given":"Muriel","family":"Sudres","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maurer","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Robinet","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bismuth","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Girard","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Dragin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Attia","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[{"name":"Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Santelmo","sequence":"additional","affiliation":[{"name":"H\u00f4pital Civil de Strasbourg, Strasbourg, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sicsic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Agnes Ginges Center for human Neurogenetics, Hadassah Hebrew University Medical Center, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talma","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Agnes Ginges Center for human Neurogenetics, Hadassah Hebrew University Medical Center, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France."},{"name":"INSERM U974, Paris, France."},{"name":"AIM, Institute of Myology, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000212371"},{"issue":"5\u20136","key":"B2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/08916930903518073","article-title":"The auto-antigen repertoire in myasthenia gravis","volume":"43","author":"Vrolix","year":"2010","journal-title":"Autoimmunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51321.x"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.011"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.015"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.011"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12217"},{"issue":"5","key":"B8","first-page":"995","article-title":"The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat","volume":"139","author":"Meinl","year":"1991","journal-title":"Am J Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115843"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01844.x"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-014-0260-8","article-title":"A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods","volume":"12","author":"Madrigal","year":"2014","journal-title":"J Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.01.005"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2010.02445.x"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838729"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0008"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.11.014"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.09.007"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51282.x"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18025"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.009"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.05.001"},{"issue":"5","key":"B24","first-page":"1359","article-title":"Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice","volume":"148","author":"Spuler","year":"1996","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.3.484"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340110"},{"issue":"8","key":"B27","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.0.CO;2-9","article-title":"Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice","volume":"29","author":"Vassilev","year":"1999","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2009.06.005"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271841"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.05.013"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288035"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1981.tb33739.x"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0267-7"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.85"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200738129"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/stem.698"},{"issue":"9","key":"B37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/leu.2011.108","article-title":"Mesenchymal stromal cell \u2018licensing\u2019: a multistep process","volume":"25","author":"Krampera","year":"2011","journal-title":"Leukemia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.11.004"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X508762"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902723"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3MR0214-109R"},{"key":"B42","article-title":"The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease","volume":"2014","author":"Toomey","year":"2014","journal-title":"Autoimmune Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.61"},{"issue":"1\u20132","key":"B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.01.003","article-title":"DAF\/CD55 and protectin\/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis","volume":"244","author":"Soltys","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16086"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-325225"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-89520-8_3"},{"issue":"1\u20132","key":"B48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"10","key":"B49","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archneur.65.10.1358","article-title":"A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis","volume":"65","author":"Ragheb","year":"2008","journal-title":"Arch Neurol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6092-z"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2002.0618"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/12.10.1381"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.11.6893"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0596"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.225"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.10.001"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088036"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-154138"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102996"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1089\/154732804323099190"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12336"},{"issue":"Pt 19","key":"B62","first-page":"4640","article-title":"Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes","volume":"125","author":"Hof-Nahor","year":"2012","journal-title":"J Cell Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.017"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/12.3.219"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.058"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.056"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8558-3"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/89665\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:49:52Z","timestamp":1779198592000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/89665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,4,6]]},"published-print":{"date-parts":[[2017,4,6]]}},"alternative-id":["10.1172\/jci.insight.89665"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.89665","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"article-number":"e89665"}}